158 related articles for article (PubMed ID: 38670584)
1. Engineering of an EPHA2-Targeted Monobody for the Detection of Colorectal Cancer.
Venu A; Zhang Y; Seong J; Hong Y; Lee WS; Min JJ
Cancer Genomics Proteomics; 2024; 21(3):285-294. PubMed ID: 38670584
[TBL] [Abstract][Full Text] [Related]
2. Engineering of monobody conjugates for human EphA2-specific optical imaging.
Kim MA; Yoon HS; Park SH; Kim DY; Pyo A; Kim HS; Min JJ; Hong Y
PLoS One; 2017; 12(7):e0180786. PubMed ID: 28686661
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of a Monobody with a Fibronectin Domain III Scaffold That Specifically Binds EphA2.
Park SH; Park S; Kim DY; Pyo A; Kimura RH; Sathirachinda A; Choy HE; Min JJ; Gambhir SS; Hong Y
PLoS One; 2015; 10(7):e0132976. PubMed ID: 26177208
[TBL] [Abstract][Full Text] [Related]
4. Production of
Pyo A; You SH; Sik Kim H; Young Kim J; Min JJ; Kim DY; Hong Y
Bioorg Med Chem Lett; 2020 Jul; 30(14):127262. PubMed ID: 32527560
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer.
De Robertis M; Loiacono L; Fusilli C; Poeta ML; Mazza T; Sanchez M; Marchionni L; Signori E; Lamorte G; Vescovi AL; Garcia-Foncillas J; Fazio VM
Clin Cancer Res; 2017 Jan; 23(1):159-170. PubMed ID: 27401248
[TBL] [Abstract][Full Text] [Related]
6. EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.
De Robertis M; Mazza T; Fusilli C; Loiacono L; Poeta ML; Sanchez M; Massi E; Lamorte G; Diodoro MG; Pescarmona E; Signori E; Pesole G; Vescovi AL; Garcia-Foncillas J; Fazio VM
Mol Cancer; 2018 Nov; 17(1):169. PubMed ID: 30501625
[TBL] [Abstract][Full Text] [Related]
7. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
[TBL] [Abstract][Full Text] [Related]
9. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
10. EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer.
Dunne PD; Dasgupta S; Blayney JK; McArt DG; Redmond KL; Weir JA; Bradley CA; Sasazuki T; Shirasawa S; Wang T; Srivastava S; Ong CW; Arthur K; Salto-Tellez M; Wilson RH; Johnston PG; Van Schaeybroeck S
Clin Cancer Res; 2016 Jan; 22(1):230-242. PubMed ID: 26283684
[TBL] [Abstract][Full Text] [Related]
11. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
13. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.
Liu X; He H; Zhang F; Hu X; Bi F; Li K; Yu H; Zhao Y; Teng X; Li J; Wang L; Zhang Y; Wu Q
Cell Death Dis; 2022 May; 13(5):483. PubMed ID: 35595748
[TBL] [Abstract][Full Text] [Related]
14. Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer.
Tröster A; Jores N; Mineev KS; Sreeramulu S; DiPrima M; Tosato G; Schwalbe H
ChemMedChem; 2023 Dec; 18(23):e202300420. PubMed ID: 37736700
[TBL] [Abstract][Full Text] [Related]
15. Circ-ACAP2 facilitates the progression of colorectal cancer through mediating miR-143-3p/FZD4 axis.
Zhang G; Liu Z; Zhong J; Lin L
Eur J Clin Invest; 2021 Dec; 51(12):e13607. PubMed ID: 34085707
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.
Stammes MA; Prevoo HA; Ter Horst MC; Groot SA; Van de Velde CJ; Chan AB; de Geus-Oei LF; Kuppen PJ; Vahrmeijer AL; Pasquale EB; Sier CF
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165374
[TBL] [Abstract][Full Text] [Related]
17. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
[TBL] [Abstract][Full Text] [Related]
18. STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 (
Lin Z; Liu Y; Xu T; Su T; Yang Y; Liang R; Gu S; Li J; Song X; Liang B; Leng Z; Li Y; Meng L; Luo Y; Chang X; Huang D; Xie L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373188
[TBL] [Abstract][Full Text] [Related]
19. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
